期刊文献+

SARI基因过表达对K562细胞系生物学影响的研究 被引量:1

Biological Effects of the SARI Over-expression on K562 Cell Line
下载PDF
导出
摘要 目的:通过构建SARI慢病毒表达载体,探讨SARI基因过表达对K562细胞生物学功能的影响。方法:采用RT-PCR方法获得目的基因并重组p LOV.CMV.GFP质粒,构建pLOV.CMV.GFP-SARI表达载体。通过测序鉴定、病毒包装和滴度测定后,获得阳性病毒颗粒,并以病毒颗粒感染K562细胞系。采用Q-PCR及Western blot方法验证感染后K562细胞SARI基因转录和蛋白水平的表达情况,同时采用CCK-8法检测K562细胞的增殖情况,以流式细胞术分析细胞凋亡和细胞周期变化。结果:利用RT-PCR方法获得SARI基因并成功构建了含SARI基因的慢病毒表达载体,从分子及蛋白水平验证了其在感染后K562细胞中的高表达;与空白组和感染空载体的Mock组相比,过表达SARI载体组的细胞增殖显著受抑、细胞凋亡率增加,而细胞周期无显著变化。结论:SARI基因过表达可抑制K562细胞的增殖并促进其凋亡,提示诱导SARI基因过表达可能对于抑制CML发生发展具有重要的作用。 Objective: To construct a lentivirus vector carrying SARI gene and to investigate its biological effects on K562 cells. Methods:SARl was amplified from the plasmid containing SARI cDNA and subcloned into pLOV. CMV. eGFP virus vector. After sequencing, lentivirus packaging, titering, the viruses of SARI-pLOV. CMV. eGFP were harvested and tansfected into the K562 cells. Real-time quantitive PCR and Western blot were performed to validate the SARI expression at the level of mRNA and protein respectively. Simultaneously, the proliferation, apoptosis and cell cycle of K562 cells were detected by CCK-8 and flow cytometry respectively. Results: The SAR/ overexpressed lentivirus vector was successfully constructed. The mRNA and protein levels of SARI increased significantly in the pLOV. CMV. eGFP-SARI group, which was confirmed by Q-PCR and Western blot; as compared with blank and mock groups, SAR/over-expression leaded to significant proliferation inhibition and increased apoptosis of K562 cells, without visible effects on cell cycle. Conclusion: the over-expression of SAR/gene obviously suppresses the cell proliferation of the K562 cells as well as promotes the apoptosis. The results implied that the induction of the SAR/gene expression may be an important candidate therapeutic method for the CML.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2015年第3期637-641,共5页 Journal of Experimental Hematology
基金 国家自然科学基金(81100356) 湖北省自然科学基金(2014CFB466)
关键词 SARI 病毒感染 凋亡 增殖 CML SAR/ transfection apoptosis proliferation CML
  • 相关文献

参考文献14

  • 1Su ZZ,Lee SG,Emdad L,et al.Cloning and characterization of SARI(suppressorof AP-1,regulated by IFN).Proc Natl Acad Sci USA,2008;105(52):20906-20911.
  • 2路钊,郑少鹏,牛静,贾弘禔,丁卫.BATF2/SARI通过抑制p53依赖的NF-κB转录活性诱导肿瘤细胞凋亡[J].中国生物化学与分子生物学报,2011,27(6):524-532. 被引量:14
  • 3Childs KS,Andrejeva J,Randall RE,et al.Mechanism of mda-5Inhibition by paramyxovirus V proteins.J Virol,2009;83(3):1465-1473.
  • 4Ma H,Liang X,Chen Y,et al.Decreased expression of BATF2 is associated with a poor prognosis in hepatocellular carcinoma.Int J Cancer,2011;128(4):771-777.
  • 5Wang C,Su Y,Zhang L,et al.The function of SARI in modulating epithelial-mesenchymal transition and lung adenocarcinoma metastasis.PLo S One,2012;7(9):e38046.
  • 6Wen H,Chen Y,Hu Z,et al.Decreased expression of BATF2 is significantly associated with poor prognosis in oral tongue squamous cell carcinoma.Oncol Rep,2014;31(1):169-174.
  • 7Deininger MW,Goldman JM,Melo JV.The molecular biology of chronic myeloid leukemia.Blood,2000;96(10):3343-3356.
  • 8JФrgensen HG,Allan EK,Jordanides NE,et al.Nilotinib exerts equipotent antiproliferative effects to imatinib and does not induce apoptosis in CD34+CML cells.Blood,2007;109(9):4016-4019.
  • 9Copland M,Hamilton A,Elrick LJ,et al.Dasatinib(BMS-354825)targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction.Blood,2006;107(11):4532-4539.
  • 10Huang Q,Yang Y,Li X,et al.Transcription suppression of SARI(suppressor of AP-1,regulated by IFN)by BCR-ABL in human leukemia cells.Tumor Biol,2011;32(6):1191-1197.

二级参考文献41

  • 1Britschgi C, Fey MF. Tumor suppressor genes in myeloid differentiation and leukemogenesis. Future Oncol, 2009 ;5 ( 2 ) : 245 - 257.
  • 2Sattler M, Salgia R. Activation of hematopoietic growth factor signal transduction pathways by the human oncogene BCR/ABL. Cytokine Growth Factor Rev, 1997 ;8( 1 ) :63 -79.
  • 3Sillaber C, Gesbert F, Frank DA, et al. STAT5 activation contributes to growth and viability in Bcr/Abl-transformed cells. Blood, 2000;95(6) :2118 -2125.
  • 4Steelman LS, Pohnert SC, Shelton JG, et al. JAK/STAT, Raf/ MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia, 2004; 18 (2) : 189 - 218.
  • 5Chinenov Y, Kerppola TK. Close encounters of many kinds: Fos- Jun interactions that mediate transcription regulatory specificity. Oncogene ,2001 ;20 (19) :2438 - 2452.
  • 6Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta, 1991 ;1072(2 -3) :129 - 157.
  • 7Eferl R, Wagner EF. AP-I: a double-edged sword in tumorigenesis. Nat Rev Cancer, 2003 ;3 ( 11 ) :859 - 868.
  • 8Zhang X, Miao X, Guo Y, et al. Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer [ J ]. Hum Mutat, 2006, 27 ( 1 ) : 110-117.
  • 9Hassler M, Singh S, Yue W W, et al. Crystal structure of the retinoblastoma protein N domain provides insight into tumor suppression, ligand interaction, and holoprotein architecture [J]. MolCell, 2007, 28(3): 371-385.
  • 10Beg A A, Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death [ J]. Science, 1996, 274(5288) : 782-784.

共引文献20

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部